Pay in 4 interest-free payments of $6.72 Learn more
Ships within 48 hours · Estimated delivery Nov 18 - Nov 23
This is a preview of subscription content, access via your institution Access options Access Nature and 54 other Nature Portfolio journals Get Nature+, our best-value online-access subscription $32.99 / 30 days cancel any time Subscribe to this journal Receive 12 print issues and online access $259.00 per year only $21.58 per issue Rent or buy this article Prices vary by article type from$1.95 to$39.95 Prices may be subject to local taxes which are calculated during checkout References Parker, J
Prior authorization forms are completed by the prescribing healthcare provider and will ask questions about the individuals eligibility, including information on their BMI and past weight loss attempts
Compared with the class of oral diabetes medications called SGLT2 inhibitors, GLP-1 therapies usually result in greater weight loss and stronger blood sugar lowering
placebo suggest patients enjoy at least as good, if not better, outcomes from the combination of therapies
